ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03168100
Brief Title: 2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

First Submitted : May 24, 2017
First Submitted that Met QC Criteria : May 24, 2017
First Posted : May 30, 2017

Last Update Submitted that Met QC Criteria : January 25, 2019
Last Update Posted : January 28, 2019